TY  - GEN
AU  - Stewart,D A
AU  - Guo,D
AU  - Glück,S
AU  - Morris,D
AU  - Chaudhry,A
AU  - deMetz,C
AU  - Klassen,J
AU  - Brown,C B
AU  - Russell,J A
TI  - Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation
SN  - 0268-3369
PY  - 2001///0125
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Blood Component Removal
KW  - methods
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Etoposide
KW  - Follow-Up Studies
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Melphalan
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Proportional Hazards Models
KW  - Risk Factors
KW  - Survival Rate
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1702541
ER  -